Remnant cholesterol and suicide attempts in untreated first-episode major depressive disorder

  • 0Department of Psychiatry, Nanjing Lishui District Psychiatric Hospital, Lishui, China.

|

|

Summary

This summary is machine-generated.

Remnant cholesterol (RC) levels show a non-linear link to suicide attempts (SA) in Chinese patients with first-episode major depressive disorder (MDD). A significant positive correlation exists when RC is below 1.99 mmol/L.

Area Of Science

  • Cardiovascular Health
  • Psychiatry
  • Biomarkers in Mental Health

Background

  • Major depressive disorder (MDD) is a leading cause of disability worldwide.
  • Suicide attempts (SA) are a critical concern in MDD patients.
  • Lipid metabolism, including remnant cholesterol (RC), is increasingly recognized for its potential role in psychiatric conditions.

Purpose Of The Study

  • To investigate the relationship between remnant cholesterol (RC) levels and suicide attempts (SA).
  • To examine this association in Chinese patients diagnosed with untreated first-episode major depressive disorder (UFE MDD).

Main Methods

  • A cohort of 1718 patients with UFE MDD was analyzed.
  • Demographic, clinical, and blood lipid data were collected.
  • Multivariable logistic regression and two-piecewise linear regression models assessed the RC-SA association, controlling for confounders.

Main Results

  • A non-linear association was found between RC and SA.
  • A significant positive correlation between RC and SA was observed when RC levels were below 1.99 mmol/L.
  • No significant correlation was found when RC levels exceeded 1.99 mmol/L.

Conclusions

  • Remnant cholesterol levels exhibit a non-linear association with suicide attempts in UFE MDD patients.
  • Elevated RC below a specific threshold (1.99 mmol/L) may indicate an increased risk for SA.
  • Further research is warranted to elucidate the mechanisms underlying this relationship.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents 01:23

174

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depressive Disorders: Etiology 01:27

26

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Depressive Disorders: MDD and Dysthymia 01:27

27

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs 01:28

262

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Depression: Overview 01:18

205

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Stress and Mental Health 01:30

67

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...